跳至主要内容
临床试验/CTRI/2024/02/062805
CTRI/2024/02/062805已完成3 期

“Efficacy and safety of Dexamethasone and Fentanyl as an adjuvant to Ropivacaine in PENG block for proximal femur surgery.”

Dr Vrishali Apte1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年2月26日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
To study postoperative duration of analgesia and requirement of rescue analgesics

研究概览

简要总结

This study will be conducted at Smt. Kashibai Navale Medical College and general hospital, Pune. After taking written informed consent, patients aged between 18 to 65 years, of either sex will be randomly allocated into two groups. Group RD patients will receive Dexamethasone 4mg as an adjuvant to 15ml 0.2% Ropivacaine in PENG block and Group RF patients will receive Fentanyl 50mcg as an adjuvant to 15ml of 0.2% Ropivacaine in PENG block.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.ASA I &II patients 2.Patients posted for proximal femur surgery under spinal anaesthesia.

排除标准

  • Patient refusal
  • Contraindication to subarachnoid block.
  • Central or peripheral neuropathies
  • Patients with bleeding disorders and those on anticoagulant therapy.
  • History of allergy to local anesthetics.
  • Infection at site of block.
  • Pregnant women.
  • Patients with psychiatric behavior.

结局指标

主要结局

To study postoperative duration of analgesia and requirement of rescue analgesics

时间窗: VAS will be assessed after shifting the patient to PACU-initially every 30 minutes for 2 hours, then every 2 hours for next 8 hours and then after every 4 hours till 24 hours

次要结局

  • To study ease for positioning for spinal Anesthesia,Patient’s satisfaction score And adverse effects if any.

研究者

发起方
Dr Vrishali Apte
申办方类型
Other [Self interest]
责任方
Principal Investigator
主要研究者

Dr Vrishali Apte

Smt. Kashibai Navale Medical College and General Hospital, Narhe, Pune

研究点 (1)

Loading locations...

相似试验

To compare two drugs dexamethasone and fentanyl as... | 临床试验